Now It's time to transition patients to The Libre 2 Plus Sensors

Libre 2 sensor will be phased out at the end of August 2025.
Find out what you need to do >

NICE Guidelines for Managing Diabetes


NICE guidelines support the use of flash glucose monitoring for all adults with T1DM or selected adults with T2DM on MDI.*

* T1DM (Type 1 Diabetes) | T2DM (Type 2 Diabetes) | MDI (multiple daily insulin injections)

 

HCP talking to their patient about how the NICE guidelines can be used with the FreeStyle Libre system
HCP talking to their patient about how the NICE guidelines can be used with the FreeStyle Libre system
HCP talking to their patient about how the NICE guidelines can be used with the FreeStyle Libre system

NICE guidelines were updated in April 2022

What does this mean for you and your patients?

Adults with T1DM

NICE guidelines support the use of the FreeStyle Libre 2 system or the FreeStyle Libre 3 system in all adults aged 18 and over with T1DM.1

Offer the FreeStyle Libre 2 system or the FreeStyle Libre 3 system to adults with T1DM

Adults with T2DM on MDI

NICE guidelines also support the use of the FreeStyle Libre 2 system in selected adults with T2DM on MDI.2 The FreeStyle Libre 2 system should be offered to adults with insulin-treated T2DM that meet any one of the below criteria:

  • they have recurrent hypoglycaemia or severe hypoglycaemia
  • they have impaired hypoglycaemia awareness
  • they have a condition or disability (including a learning disability or cognitive impairment) that means they cannot self-monitor their blood glucose by capillary blood glucose monitoring but could use an isCGM device (or have it scanned for them)
  • they would otherwise be advised to self-measure at least 8 times a day

Offer the FreeStyle Libre 2 system to adults with insulin-treated T2DM who would otherwise need help from a care worker or healthcare professional to monitor their blood glucose.

 

 

NICE now recommends HCL Systems For Selected People with T1D3

The new NICE technology appraisal recommendation means more type 1 patients qualify for a Hybrid Closed (HCL) compatible real-time CGM system.

Connected insulin pumps can prevent low and high glucose levels by automatically adjusting insulin delivery based on Libre 2 Plus or Libre 3 sensor readings.

A healthcare professional and a patient looking at a computer monitor together.

Meet the FreeStyle Libre systems^

The FreeStyle Libre systems^ exist to empower those living with diabetes to make diabetes self-management choices and to help you, as their healthcare professional, to support them in their journey.

The FreeStyle Libre 2 System

Minute-to-minute glucose readings sent to your patient's smartphone◊,ǁ to help them manage their diabetes more confidently.4
 

The FreeStyle Libre 3 System

Your patients know sooner, can act faster and be ready to avoid hypos with our next-gen continuous glucose monitoring.◊◊
 

Work in Primary Care?

Explore our dedicated Libre Hub for everything you need to get patients started and prescribe the FreeStyle Libre 2 system.

Access & further learning

The FreeStyle Libre 2 system is available to prescribe for eligible patients in the UK. Get support accessing the FreeStyle Libre Portfolio for your patients and learn more about the products.

Expanding Access Case Studies

Learn to initiate access to glucose-sensing technology in your local health authority

Read case studies from local health authorities who have initiated access to glucose-sensing technology to reduce health inequalities and improve patient health outcomes.

Contact Market Access Team

If you require further information on accessing The FreeStyle Libre systems^ in your area, the Abbott Market Access Team can support you through this process.

Complete our contact form below and an Abbott representative will get in touch.

Join the Libre Academy

Education & Learning Centre

Complete interactive, bite-sized eLearning modules designed to help you feel confident in supporting your patients and using the latest techology to achieve better clinical outcomes.

Contact the Market Access Team

As a registered Healthcare Professional by completing the form below an Abbott representative will contact you regarding your enquiry.

Please provide a valid first name.
Please enter a valid last name.
Please enter the email address.
The subject of your message must not contain special characters.
Please enter a message.

Required fields are indicated with an asterisk (*).

References & Disclaimers

Images are for illustrative purposes only. Not actual patient data.

1. NICE guideline NG17 (2015) Last updated: 17 August 2022; available at https://www.nice.org.uk/guidance/ng17. Accessed Jan 2023.

2. NICE guideline NG28 (2015) Last updated: 29 June 2022; available at https://www.nice.org.uk/guidance/ng28. Accessed Jan 2023.

3. NICE technology appraisal guidance TA943 (2023). Available at https://www.nice.org.uk/guidance/ta943. Accessed April 2024.

4. Fokkert M. BMJ Open Diab Res Care (2019): http://dx.doi.org/10.1136/bmjdrc-2019-000809.

† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.

^ FreeStyle Libre Systems refer to FreeStyle Libre 2 and FreeStyle Libre 3 Systems.

◊ The LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView. 

◊◊ The Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Sharing of glucose data requires registration with Libreview.

ǁ Glucose readings are automatically displayed in the LibreLink app only when your patients’ smartphone and sensor are connected and in range.

Loading...